Cardiovascular diseases kill more people every year globally than any other cause. A new daily pill could slash that risk, but experts are divided on the ethics of the treatment, The New York Times reports. Just one “polypill” a day—a single capsule containing aspirin, two blood pressure drugs, and a cholesterol-lowering statin—reduced the risk of all cardiovascular events by around one-third, and heart attacks by half, for nearly 7000 Iranian villagers, researchers report this week in The Lancet. But while the results of the study were promising, some experts stress the dangers of giving out a “one-size-fits-all” medication—especially because each of the drugs in the polypill come with their own side effects.
Click here for free access to our latest coronavirus/COVID-19 research, commentary, and news.
Support nonprofit science journalism
Science’s extensive COVID-19 coverage is free to all readers. To support our nonprofit science journalism, please make a tax-deductible gift today.